These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product. Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412 [TBL] [Abstract][Full Text] [Related]
24. Vaginal delivery of contraceptives. Sitruk-Ware R Expert Opin Drug Deliv; 2005 Jul; 2(4):729-36. PubMed ID: 16296797 [TBL] [Abstract][Full Text] [Related]
25. What impact has England's Teenage Pregnancy Strategy had on young people's knowledge of and access to contraceptive services? French RS; Mercer CH; Kane R; Kingori P; Stephenson JM; Wilkinson P; Grundy C; Lachowycz K; Jacklin P; Stevens M; Brooker S; Wellings K J Adolesc Health; 2007 Dec; 41(6):594-601. PubMed ID: 18023789 [TBL] [Abstract][Full Text] [Related]
26. Increasing access in contraceptive coverage by broadening contraceptive options. Introduction. Morrow T Manag Care Interface; 2005; 18 Suppl A():2-3. PubMed ID: 15682624 [No Abstract] [Full Text] [Related]
27. In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and Stephania hernandifolia on human semen. Paul D; Bera S; Jana D; Maiti R; Ghosh D Contraception; 2006 Mar; 73(3):284-8. PubMed ID: 16472572 [TBL] [Abstract][Full Text] [Related]
28. Delivery options for contraceptives. Sitruk-Ware R Drug Discov Today; 2005 Jul; 10(14):977-85. PubMed ID: 16023056 [TBL] [Abstract][Full Text] [Related]
30. [Use of a new vaginal contraceptive; polyclinic trials]. THOMMEN DH Praxis; 1955 Apr; 44(15):334-6. PubMed ID: 14384674 [No Abstract] [Full Text] [Related]
31. Tolerance studies with a new contraceptive gel. WARNER MP J Am Med Womens Assoc; 1959 May; 14(5):412-4. PubMed ID: 13654056 [No Abstract] [Full Text] [Related]
32. Effectiveness of preceptin; study of its use as sole contraceptive agent in an urban clinic population. FINKELSTEIN R; GUTTMACHER A; GOLDBERG R Obstet Gynecol; 1954 Aug; 4(2):217-21. PubMed ID: 13185537 [No Abstract] [Full Text] [Related]
33. The potential impact of community-based distribution programmes on contraceptive uptake in resource-poor settings: evidence from Ethiopia. Tawye Y; Jotie F; Shigu T; Ngom P; Maggwa N Afr J Reprod Health; 2005 Dec; 9(3):15-26. PubMed ID: 16623186 [TBL] [Abstract][Full Text] [Related]
34. Intravaginal contraceptive study. Phase II. Physiology. (A direct test for protective potential). JOHNSON VE; MASTERS WH West J Surg Obstet Gynecol; 1963; 71():144-53. PubMed ID: 14029355 [No Abstract] [Full Text] [Related]
35. In vitro spermicidal activity of peptides from amphibian skin: dermaseptin S4 and derivatives. Zairi A; Serres C; Tangy F; Jouannet P; Hani K Bioorg Med Chem; 2008 Jan; 16(1):266-75. PubMed ID: 17942313 [TBL] [Abstract][Full Text] [Related]
36. Factors associated with contraceptive use in Tehran, Iran. Sadat-Hashemi SM; Ghorbani R; Majdabadi HA; Farahani FK Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):148-53. PubMed ID: 17559013 [TBL] [Abstract][Full Text] [Related]